Supreme Court Denies Review in NFL Concussion Case, Clearing the Way for Landmark Settlement

On Monday, the United States Supreme Court denied challenges to the pending settlement reached among retired NFL players and the league, clearing the way for the benefits process to move forward. The Supreme Court’s decision to deny review removes the final obstacle to implementation of the landmark settlement to provide care for retired NFL players suffering from brain-related injuries […]

December 13, 2016

football

On Monday, the United States Supreme Court denied challenges to the pending settlement reached among retired NFL players and the league, clearing the way for the benefits process to move forward.

The Supreme Court’s decision to deny review removes the final obstacle to implementation of the landmark settlement to provide care for retired NFL players suffering from brain-related injuries as a result of hits sustained during their playing careers.

Christopher Seeger, co-lead counsel for the retired NFL player class plaintiffs, said, “This decision means that, finally, retired NFL players will receive much-needed care and support for the serious neurocognitive injuries they are facing. These courageous men and their families, who in the face of great adversity took on the NFL, have made history. Despite the difficult health situations retired players face today, and that many more will unfortunately face in the future, they can take comfort in the fact that this settlement’s significant and immediate benefits will finally become available to them and last for decades to come.”

“Today’s decision ushers in the benefits process, which we expect will open this spring. With a 99% participation rate in the settlement, and more than 11,000 retired players already pre-registering for benefits, it is clear these programs are highly anticipated by the NFL alumni community,” Mr. Seeger said. “Class members will soon be receiving more information by mail, and we encourage them to visit NFLconcussionsettlement.com for updates on the registration and claims process.”

Related News

October 30, 2026
Seeger Weiss Named Litigation Department of the Year for Products Liability and Mass Torts at the 2026 New Jersey Legal Awards

New Jersey-based Seeger Weiss has been named Litigation Department of the Year in the Products Liability and Mass Torts category at the New Jersey Law Journal’s 2026 New Jersey Legal Awards. Winners were announced on October 29, 2026, at The Palace at Somerset Park in Somerset, New Jersey. Over the past year, the department took […]

Read More
October 25, 2026
Seeger Weiss Partner Christopher A. Seeger Receives Inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law

Seeger Weiss Partner Christopher Seeger received the inaugural Monroe E. Price Award from the Benjamin N. Cardozo School of Law, his alma mater, at the school’s 50th Anniversary Gala at the Hall des Lumières in New York City on October 22, 2026. The award is named for Monroe Price, who served as Dean of Cardozo […]

Read More
October 23, 2026
Seeger Weiss’s Christopher A. Seeger Appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation

Seeger Weiss LLP is pleased to announce that Partner Christopher A. Seeger has been appointed Co-Lead Counsel in In re: Dupixent (Dupilumab) Products Liability Litigation, MDL No. 3180, pending in the U.S. District Court for the District of New Jersey. The litigation involves claims that Dupixent, an injectable biologic prescribed to treat inflammatory conditions including […]

Read More
↑